Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Newell Farms
WARNING LETTER
•Newell Farms•May 14, 2014

FDA WARNING_LETTER - Newell Farms - May 14, 2014

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Newell Farms
Record Details

On May 6, 8, and 14, 2014, the FDA conducted an investigation of Newell Farms' dairy operation, identifying multiple violations of the Federal Food, Drug, and Cosmetic Act. The primary violation involved the sale of an adulterated cow for slaughter on October 21, 2013. Tissue analysis revealed desfuroylceftiofur residues at 6.28 ppm in the kidney (tolerance 0.4 ppm) and flunixin residues at 0.879 ppm in the liver (tolerance 0.125 ppm), rendering the food adulterated under 21 U.S.C. § 342(a)(2)(C)(ii). The investigation also found that Newell Farms holds animals under inadequate conditions, making it likely that medicated animals with harmful drug residues could enter the food supply, violating 21 U.S.C. § 342(a)(4). This was supported by findings of incomplete treatment records and expired drugs. Furthermore, the firm adulterated new animal drugs, Naxcel and Prevail, through extralabel use not directed by approved labeling or a veterinarian's prescription. This extralabel use was not under the supervision of a licensed veterinarian (21 C.F.R. 530.11(a)) and resulted in illegal drug residues (21 C.F.R. 530.11(d)), causing the drugs to be unsafe and adulterated under 21 U.S.C. § 351(a)(5). Newell Farms must take prompt corrective actions and establish preventative procedures, responding to the FDA within 15 working days to avoid potential regulatory actions like seizure or injunction.

Company
Newell Farms
Inspection Date
May 14, 2014
Product Type
Drugs
Office
Detroit District Office
People
  • Art O. Czabaniuk (Program Division Director)
  • Melanie A. Hart
Open in Dashboard

ID · ed771384-7eeb-4e94-99da-769383532762

Violation Codes10
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 342(a)(4)21 U.S.C. 360b21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 U.S.C. 351(a)(5)21 CFR 530.3(a)21 CFR 530.11(a)21 CFR 530.11(d)21 CFR 530

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.